cabazitaxel accord
accord healthcare s.l.u. - cabazitaxel - prostatic neoplasmer, kastrering-resistant - antineoplastiske midler - treatment of patients with hormone refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen.
fentanyl ratiopharm 75 mikrog/ time
ratiopharm gmbh - fentanyl - depotplaster - 75 mikrog/ time
fentanyl ratiopharm 12 mikrog/ time
ratiopharm gmbh - fentanyl - depotplaster - 12 mikrog/ time
fentanyl ratiopharm 25 mikrog/ time
ratiopharm gmbh - fentanyl - depotplaster - 25 mikrog/ time
fentanyl ratiopharm 50 mikrog/ time
ratiopharm gmbh - fentanyl - depotplaster - 50 mikrog/ time
fentanyl ratiopharm 100 mikrog/ time
ratiopharm gmbh - fentanyl - depotplaster - 100 mikrog/ time
jevtana 60 mg
orifarm as - kabazitaksel - konsentrat og væske til infusjonsvæske, oppløsning - 60 mg
cabazitaxel stada 20 mg/ ml
stada arzneimittel ag - kabazitaksel - konsentrat til infusjonsvæske, oppløsning - 20 mg/ ml
mektovi 15 mg
2care4 aps - binimetinib - tablett, filmdrasjert - 15 mg
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulær blokkade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.